Human tumor microenvironment chip evaluates the consequences of platelet extravasation and combinatorial antitumor-antiplatelet therapy in ovarian cancer
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Platelets extravasate from the circulation into tumor microenvironment, enable metastasis, and confer resistance to chemotherapy in several cancers. Therefore, arresting tumor-platelet cross-talk with effective and atoxic antiplatelet agents in combination with anticancer drugs may serve as an effective cancer treatment strategy. To test this concept, we create an ovarian tumor microenvironment chip (OTME-Chip) that consists of a platelet-perfused tumor microenvironment and which recapitulates platelet extravasation and its consequences. By including gene-edited tumors and RNA sequencing, this organ-on-chip revealed that platelets and tumors interact through glycoprotein VI (GPVI) and tumor galectin-3 under shear. Last, as proof of principle of a clinical trial, we showed that a GPVI inhibitor, Revacept, impairs metastatic potential and improves chemotherapy. Since GPVI is an antithrombotic target that does not impair hemostasis, it represents a safe cancer therapeutic. We propose that OTME-Chip could be deployed to study other vascular and hematological targets in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“They also showed that the administration of GPVI led to reduced cancer proliferation, invasion and chemotherapy resistance.”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Saha et al., 2021
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In a subsequent study with an improved microfluidic chip design integrating a more physiological ECM, Saha et al. explored the effectiveness of a glycoprotein VI (GPVI) inhibitor to limit platelet extravasation (Saha et al., 2021).”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Saha et al., 2021
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Their microfluidic chip revealed that the interaction of platelets and tumors occurs via glycoprotein VI and tumor galectin-3, a protein typically overexpressed in advanced stages of ovarian cancer.”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Saha et al., 2021
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Labelle, M., Begum, S., & Hynes, R. O. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.09.009 · Cited by 1,833
Neutrophils in cancer: Neutral no more
Coffelt, S. B., Wellenstein, M. D., & de Visser, K. E. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.52 · Cited by 1,830
Neutrophils support lung colonization of metastasis-initiating breast cancer cells
Wculek, S. K., & Malanchi, I. (2015) · Nature · doi:10.1038/nature16140 · Cited by 1,003
Three-dimensional microfluidic model for tumor cell intravasation and endothelial barrier function
Zervantonakis, I. K., Hughes-Alford, S. K., Charest, J. L., Condeelis, J. S., Gertler, F. B., & Kamm, R. D. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1210182109 · Cited by 872 · cited 1×
“This relative simplicity and a provision to do analytics is a strength of our OTME-Chip, which is also not radically different from its prior versions (20) and consistent with prior models (39).”
ResultParaneoplastic thrombocytosis in ovarian cancer
Stone, R. L., Nick, A. M., McNeish, I. A., Balkwill, F., Han, H. D., Bottsford-Miller, J., Rupaimoole, R., Armaiz-Pena, G. N., Pecot, C. V., Coward, J., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110352 · Cited by 812
Self-citationMicrofabrication of human organs-on-chips
Huh, D., Kim, H. J., Fraser, J. P., Shea, D. E., Khan, M., Bahinski, A., Hamilton, G. A., & Ingber, D. E. (2013) · Nature Protocols · doi:10.1038/nprot.2013.137 · Cited by 712
Role of platelets and platelet receptors in cancer metastasis
Schlesinger, M. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0669-2 · Cited by 690
The Platelet Lifeline to Cancer: Challenges and Opportunities
Haemmerle, M., Stone, R. L., Menter, D. G., Afshar-Kharghan, V., & Sood, A. K. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.002 · Cited by 638
Self-citationCOSMID: A Web-based Tool for Identifying and Validating CRISPR/Cas Off-target Sites
Cradick, T. J., Qiu, P., Lee, C. M., Fine, E. J., & Bao, G. (2014) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2014.64 · Cited by 408
Self-citationChen, M. B., Whisler, J. A., Fröse, J., Yu, C., Shin, Y., & Kamm, R. D. (2017) · Nature Protocols · doi:10.1038/nprot.2017.018 · Cited by 385
Cited by
Advances in 3D bioprinting of tissues/organs for regenerative medicine and in-vitro models
Jain, P., Kathuria, H., & Dubey, N. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121639 · Cited by 237
The dynamic role of platelets in cancer progression and their therapeutic implications
Li, S., Lu, Z., Wu, S., Chu, T., Li, B., Qi, F., Zhao, Y., & Nie, G. (2024) · Nature Reviews Cancer · doi:10.1038/s41568-023-00639-6 · Cited by 214
Du, Y., Wang, Y., Bao, Q., Xu, X., Xu, C., Wang, S., Liu, Q., Liu, F., Zeng, Y., Wang, Y., et al. (2024) · Advanced Materials · doi:10.1002/adma.202412815 · Cited by 112
From Organ-on-a-Chip to Human-on-a-Chip: A Review of Research Progress and Latest Applications
Huang, Y., Liu, T., Huang, Q., & Wang, Y. (2024) · ACS Sensors · doi:10.1021/acssensors.4c00004 · Cited by 110
Seo, S., Nah, S.-Y., Lee, K., Choi, N., & Kim, H. N. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202106860 · Cited by 94
Cancer-on-a-Chip: Models for Studying Metastasis
Zhang, X., Karim, M., Hasan, M. M., Hooper, J., Wahab, R., Roy, S., & Al-Hilal, T. A. (2022) · Cancers · doi:10.3390/cancers14030648 · Cited by 71
Organ-on-a-chip: future of female reproductive pathophysiological models
Deng, Z., Dai, F., Wang, R., Deng, H., Yin, T., Cheng, Y., & Chen, G. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02651-w · Cited by 70
Steinberg, E., Friedman, R., Goldstein, Y., Friedman, N., Beharier, O., Demma, J. A., Zamir, G. A., Hubert, A., & Benny, O. (2023) · Communications Biology · doi:10.1038/s42003-023-05531-5 · Cited by 64
Mansour, A. A., Krautter, F., Zhi, Z., Iqbal, A. J., & Recio, C. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01690-7 · Cited by 56
CRISPR/Cas9 application in cancer therapy: a pioneering genome editing tool
Baghini, S. S., Gardanova, Z. R., Abadi, S. A. H., Zaman, B. A., İlhan, A., Shomali, N., Adili, A., Moghaddar, R., & Yaseri, A. F. (2022) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-022-00336-6 · Cited by 53
Ciucci, A., Buttarelli, M., Fagotti, A., Scambia, G., & Gallo, D. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04395-y · Cited by 51
Cancer Models on Chip: Paving the Way to Large‐Scale Trial Applications
Gil, J. F., Moura, C. S., Silvério, V., Gonçalves, G., & Santos, H. A. (2023) · Advanced Materials · doi:10.1002/adma.202300692 · Cited by 49
The role of coagulome in the tumor immune microenvironment
Wahab, R., Hasan, M. M., Azam, Z., Grippo, P. J., & Al-Hilal, T. A. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115027 · Cited by 46
Platelets in the tumor microenvironment and their biological effects on cancer hallmarks
Chen, L., Zhu, C., Pan, F., Chen, Y., Xiong, L., Li, Y., Chu, X., & Huang, G. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1121401 · Cited by 44
Review: 3D cell models for organ-on-a-chip applications
Żuchowska, A., Baranowska, P., Flont, M., Brzózka, Z., & Jastrzębska, E. (2024) · Analytica Chimica Acta · doi:10.1016/j.aca.2024.342413 · Cited by 44
Recent advances in microfluidics-based cell migration research
Ren, J., Wang, N., Guo, P., Fan, Y., Lin, F., & Wu, J. (2022) · Lab on a Chip · doi:10.1039/d2lc00397j · Cited by 40
On-chip modeling of tumor evolution: Advances, challenges and opportunities
Li, C., Holman, J. B., Shi, Z., Qiu, B., & Ding, W. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100724 · Cited by 39
Galectin functions in cancer-associated inflammation and thrombosis
Kruk, L., Braun, A., Cosset, E. C., Gudermann, T. W., & Mammadova‐Bach, E. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1052959 · Cited by 36
Recent advances in vascularized tumor-on-a-chip
Huang, C. B. X., & Tu, T.-Y. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1150332 · Cited by 34
“An upgrade from their previous OvCa-Chip, the new OTMEChip (61) has an additional gel channel on each lateral side of the tumor compartment separated by a micropillar, which allows the investigation of matrix invasion.”
MethodExperimental models for ovarian cancer research
Tsang, S. I., Hassan, A. A., To, S. K. Y., & Wong, A. S. T. (2022) · Experimental Cell Research · doi:10.1016/j.yexcr.2022.113150 · Cited by 27
Tronolone, J. J., Mathur, T., Chaftari, C. P., & Jain, A. (2023) · Annals of Biomedical Engineering · doi:10.1007/s10439-023-03177-2 · Cited by 27
Self-citationRecent advances in cancer-on-a-chip tissue models to dissect the tumour microenvironment
Seaman, K., Sun, Y., & You, L. (2023) · Med-X · doi:10.1007/s44258-023-00011-1 · Cited by 26
Vascularized tumor models for the evaluation of drug delivery systems: a paradigm shift
Lopez-Vince, E., Wilhelm, C., & Simón‐Yarza, T. (2024) · Drug Delivery and Translational Research · doi:10.1007/s13346-024-01580-3 · Cited by 26
How organ-on-a-chip is advancing cancer research and oncology - a cancer hallmarks’ perspective
Avula, L. R., & Grodzinski, P. A. (2024) · Frontiers in Lab on a Chip Technologies · doi:10.3389/frlct.2024.1487377 · Cited by 26
Pillai, S., Kwan, J. C., Yaziji, F., Yu, H., & Tran, S. D. (2023) · Cancers · doi:10.3390/cancers15153894 · Cited by 25
Galectin‐9 activates platelet ITAM receptors glycoprotein VI and C‐type lectin‐like receptor‐2
Zhi, Z., Jooss, N. J., Sun, Y. E., Colicchia, M., Slater, A., Morán, L. A., Cheung, H. Y. F., Di, Y., Rayes, J., Poulter, N. S., et al. (2021) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.15625 · Cited by 24
Psilopatis, I., Sykaras, A. G., Mandrakis, G., Vrettou, K., & Theocharis, S. E. (2022) · Biomedicines · doi:10.3390/biomedicines11010001 · Cited by 23
In Vitro Models of Ovarian Cancer: Bridging the Gap between Pathophysiology and Mechanistic Models
Lopez, E., Kamboj, S., Chen, C., Wang, Z., Kellouche, S., Leroy‐Dudal, J., Carreiras, F., Lambert, A., & Aimé, C. (2023) · Biomolecules · doi:10.3390/biom13010103 · Cited by 23
Targeting glycoprotein VI to disrupt platelet-mediated tumor cell extravasation
Tesfamariam, B., & Wood, S. C. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106301 · Cited by 21
Ghosh, L. D., Mathur, T., Tronolone, J. J., Chuong, A. B., Rangel, K., Corvigno, S., Sood, A. K., & Jain, A. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202304263 · Cited by 21
Self-citationPlatelets and circulating (tumor) cells: partners in promoting metastatic cancer
Gautam, D., Clarke, E. M., Roweth, H. G., Smith-Oliver, M. R., & Battinelli, E. M. (2024) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000852 · Cited by 19
Microfluidics as a promising technology for personalized medicine
Roudsari, Z. O., Esmaeili, Z., Nasirzadeh, N., Keshel, S. H., Sefat, F., Bakhtyari, H., & Nadri, S. (2024) · Bioimpacts · doi:10.34172/bi.29944 · Cited by 18
Glycan-Lectin interactions between platelets and tumor cells drive hematogenous metastasis
Shu, L., Lin, S., Zhou, S., & Yuan, T. (2024) · Platelets · doi:10.1080/09537104.2024.2315037 · Cited by 18
Kim, H., Cho, S., & Kim, H. N. (2025) · Macromolecular Bioscience · doi:10.1002/mabi.202500240 · Cited by 18
Ngo, H. T., Amartumur, S., Tran, V. T. A., Tran, M., Diep, Y. N., Cho, H., & Lee, L. P. (2023) · Biosensors · doi:10.3390/bios13020231 · Cited by 17
Wang, H., Xu, Y., & Guo, Y. C. (2024) · Journal of Ovarian Research · doi:10.1186/s13048-024-01377-5 · Cited by 16
Battistini, C., & Cavallaro, U. (2023) · Cancers · doi:10.3390/cancers15020368 · Cited by 15
Advances in organ‐on‐a‐chip for the treatment of cardiovascular diseases
Liu, J., & Wang, Y. (2023) · MedComm – Biomaterials and Applications · doi:10.1002/mba2.63 · Cited by 14
Microphysiological systems as models for immunologically ‘cold’ tumors
Gaebler, D., Hachey, S. J., & Hughes, C. C. W. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1389012 · Cited by 14
Kumar, N., Samanta, B., Manattayil, J. K., Raghunathan, V., Sen, P., & Bhat, R. (2025) · Small · doi:10.1002/smll.202405998 · Cited by 14
Functional biomaterials for biomimetic 3D in vitro tumor microenvironment modeling
Ahmed, T. (2023) · In vitro models · doi:10.1007/s44164-023-00043-2 · Cited by 14
Targeted Cancer Therapy‐on‐A‐Chip
Abed, H., Radha, R., Anjum, S., Paul, V., AlSawaftah, N., Pitt, W. G., Ashammakhi, N. A., & Husseini, G. A. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202400833 · Cited by 13
Revealing profile of cancer-educated platelets and their factors to foster immunotherapy development
Trivanović, D. I., Mojsilović, S. B., Bogosavljević, N., Jurišić, V., & Jauković, A. (2023) · Translational Oncology · doi:10.1016/j.tranon.2023.101871 · Cited by 12
The Balance Between Shear Flow and Extracellular Matrix in Ovarian Cancer‐on‐Chip
Chen, C., Boché, A., Wang, Z., Lopez, E., Peng, J., Carreiras, F., Schanne‐Klein, M., Chen, Y., Lambert, A., & Aimé, C. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202400938 · Cited by 11
Hydrogel Design to Understand and Guide 3D Cell Migration
Xu, K. L., Mauck, R. L., & Burdick, J. A. (2025) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-025-00395-z · Cited by 11
Blocking platelet glycoprotein VI (GPVI) as a promising antithrombotic treatment
Li, R., Qiu, Z., Cui, Y., & Xiang, Q. (2025) · Drug Discovery Today · doi:10.1016/j.drudis.2025.104473 · Cited by 11
Bortot, B., Mangogna, A., Peacock, B., Lees, R., Valle, F., Brucale, M., Tassinari, S., Romano, F., Ricci, G., & Biffi, S. (2022) · Cancers · doi:10.3390/cancers14174100 · Cited by 11
Banerjee, P., Olmsted‐Davis, E. A., Deswal, A. M., Nguyen, M. T. H., Koutroumpakis, E., Palaskas, N., Lin, S. H., Kotla, S., Reyes‐Gibby, C. C., Yeung, S. J., et al. (2022) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2022.13 · Cited by 12
Self-citationTruong, N., Zahra, A., Lintao, R. C. V., Chauhan, R., Bento, G. F. C., Vidal, M. S., Kim, S., Lam, P. Y., Conrads, T. P., Conrads, K. A., et al. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1568389 · Cited by 10
Unlocking the intricacies: Exploring the complex interplay between platelets and ovarian cancer
Xie, Q., Zhou, J., He, C., Xu, Y., Tao, F., & Hu, M. (2024) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2024.104465 · Cited by 10
Mayo, L. N., & Kutys, M. L. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00173.2022 · Cited by 9
Perspectives of metal-organic framework nanosystem to overcome tumor drug resistance
Wang, H., Li, S., Yang, Y., Zhang, L., Zhang, Y., & Wei, T. (2022) · Cancer Drug Resistance · doi:10.20517/cdr.2022.76 · Cited by 9
A bio-fabricated tesla valves and ultrasound waves-powered blood plasma viscometer
Chen, W., Mao, X., Zhu, W., Xu, Z., Cai, B., & Shen, H. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1394373 · Cited by 9
Unveiling the “Dark Matter” of platelet involvement in tumor microenvironment
Zhang, P., Zu, R., Zhang, X., Ren, H., Rao, L., Wang, D., Li, T. X., Leng, P., & Luo, H. (2025) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2025.101218 · Cited by 9
Combinatorial Drug Screening Based on Massive 3D Tumor Cultures Using Micropatterned Array Chips
Fu, W., Sun, M., Zhang, J., Xuanyuan, T., Liu, X., Zhou, Y., & Liu, W. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.2c04816 · Cited by 8
Isingizwe, Z. R., Meelheim, B. A., & Benbrook, D. M. (2024) · Cancers · doi:10.3390/cancers16213583 · Cited by 8
Serum Anti-BRAT1 is a Common Molecular Biomarker for Gastrointestinal Cancers and Atherosclerosis
Hu, L., Liu, J., Shimada, H., Ito, M., Sugimoto, K., Hiwasa, T., Zhou, Q., Li, J., Shen, S., & Wang, H. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.870086 · Cited by 8
Zheng, S., Su, Y.-Y., Cai, F.-L., Xu, D.-F., & Xu, Y. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1669482 · Cited by 7
Heydari, F., Chermehini, N. Y., Safari, Z., Hamblin, M. R., & Naghinezhad, J. (2026) · Cancer Nanotechnology · doi:10.1186/s12645-026-00375-0 · Cited by 7
Tumor-platelet cross talk in cancer: mechanisms, thrombotic risk, and translational opportunities
dos Santos, B. G., Li, Z., & Barrett, T. J. (2026) · Blood Advances · doi:10.1182/bloodadvances.2026019991 · Cited by 7
Dhar, D., Chatterjee, J., & Das, S. (2025) · RSC Advances · doi:10.1039/d5ra02192h · Cited by 7
The prospects of microphysiological systems in modeling platelet pathophysiology in cancer
Ghosh, L. D., & Jain, A. (2023) · Platelets · doi:10.1080/09537104.2023.2247489 · Cited by 7
Self-citationPlatelets: tailoring metastasis treatment
Mittelheisser, V., Liboni, C., Trivigno, S. M. G., Lefèbvre, O., Mangin, P., & Goetz, J. G. (2025) · Trends in cancer · doi:10.1016/j.trecan.2025.06.012 · Cited by 6
Platelet‑circulating tumor cell crosstalk: A pivotal target in cancer diagnosis and therapy (Review)
Zhang, L., Yuan, Y., Deng, Y., Wang, L., & Chen, F. (2025) · Oncology Reports · doi:10.3892/or.2025.9007 · Cited by 6
Pre-treatment thrombocytosis and ovarian cancer survival: A meta-analysis
Pergialiotis, V., Vokotopoulou, L. V., Vlachos, D., Liontos, M., Kontomanolis, E. N., & Thomakos, N. (2024) · European Journal of Obstetrics & Gynecology and Reproductive Biology X · doi:10.1016/j.eurox.2024.100312 · Cited by 5
Li, X., Ni, X., Sun, W., Liu, J., Shang, Y., Liu, H., & Tu, J. Y. (2024) · Physics of Fluids · doi:10.1063/5.0206053 · Cited by 5
Platelets: Novel Biomaterials for Cancer Diagnosis and Therapeutic Delivery
Wang, X., Chen, J., & Shi, H. (2025) · MedComm – Biomaterials and Applications · doi:10.1002/mba2.70010 · Cited by 5
Tumour-on-Chip Models for the Study of Ovarian Cancer: Current Challenges and Future Prospects
Lim, S. Y., Aboelnasr, L. S., & El-Bahrawy, M. A. (2025) · Cancers · doi:10.3390/cancers17193239 · Cited by 4
Xue, M., Bu, Z., Ke, K., Tian, J., Zheng, X.-Z., Neamati, N., Ma, J., Yu, H., Li, W., Dong, Q., et al. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157475 · Cited by 4
Minimal Collagen-Binding Epitope of Glycoprotein VI in Human and Mouse Platelets
Han, C., Ren, P., Mamtimin, M., Kruk, L., Sarukhanyan, E., Li, C., Anders, H., Dandekar, T., Krüger, I., Elvers, M., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11020423 · Cited by 3
Tumor Microenvironment of Epithelial Ovarian Cancer
Perkins, R. S., Choi, W.-Y., & Zhang, M. S. J. A. W. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1013212 · Cited by 3
A narrative review for platelets and their RNAs in cancers: New concepts and clinical perspectives
Xiang, Y., Xiang, P., Zhang, L.-Y., Li, Y., & Zhang, J. (2022) · Medicine · doi:10.1097/md.0000000000032539 · Cited by 3
Advances in the construction of human organs-on-chips
Yi, Z., & Gu, Z. (2023) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2023-0435 · Cited by 3
Borrego, E. A., Pérez, J. L. G., Esparza, A., Delgado, P., Moreno, K., Poon, W., Chambers, D., Joddar, B., & Natividad-Diaz, S. L. (2025) · Discover Applied Sciences · doi:10.1007/s42452-025-07523-y · Cited by 2
Organ-on-chip technologies at the cancer–thrombosis interface
Marques, I. S., Almeida, R., & Costa, P. F. (2025) · Trends in biotechnology · doi:10.1016/j.tibtech.2025.10.001 · Cited by 2
Osmanoğlu, Ö., Özer, E., Gupta, S. K., Heinze, K. G., Schulze, H., & Dandekar, T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110780 · Cited by 2
Fonte, R., Bolognino, I., Sommonte, F., Serratì, S., Fasano, R., Arduino, I., Iacobazzi, R. M., Denora, N., Perego, P., Rossi, G., et al. (2026) · Discover Nano · doi:10.1186/s11671-026-04487-9 · Cited by 2
Models of High-Grade Serous Ovarian Carcinoma
Pundel, O. J., & Neel, B. G. (2025) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041949 · Cited by 2
Ji, L., Hl, L., & Zhu, W. (2026) · Human Cell · doi:10.1007/s13577-026-01430-z · Cited by 1
Ma, W., Tian, H., Shi, J., Deng, J., Hu, N., Xu, W., Kikkawa, A., Tanaka, K., Luo, C., Kamei, K., et al. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.168997 · Cited by 1
3-layer lung cancer invasion model for evaluating MMP-targeted anti-metastatic therapeutics
Kim, G. M., Lee, Y., Park, S. H., Kim, I.-S., Lee, H., & Jung, S. (2026) · Biomedical Materials · doi:10.1088/1748-605x/ae834f · Cited by 1
Models of high-grade serous carcinoma of tubo-ovarian origin
Padmanabhan, A., Dwivedi, S. K. D., Merritt, M. A., Verma, P., Buckanovich, R. J., Lang, J. D., Dimmick, H. L., Nephew, K. P., Drapkin, R., Brubaker, L. W., et al. (2026) · Oncology Reviews · doi:10.3389/or.2026.1849834 · Cited by 1
Heydari, F., Fahmi, S., Alqassimi, S., Mansuri, N., Al-Samawi, R. I., Mozaffari, F., Hamblin, M. R., & Naghinezhad, J. (2026) · Clinical & Experimental Metastasis · doi:10.1007/s10585-026-10424-y · Cited by 1
Dhar, D., Chatterjee, J., & Das, S. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5095289
Tumor-on-a-Chip: From Biomimetic Tumor-Immune Microenvironments to Therapeutic Insights
Çetin, Y. (2025) · Biochemistry · doi:10.5772/intechopen.1012047
Wang, J., Lin, C., Zhang, P., Huang, X., Zhou, W., Wu, M., Wang, J., Sun, F., & Chen, B. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.108053
Yang, X., Zhu, H., Zou, X., & Chen, Q. (2026) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2026061544
Lab-on-a-Chip Modeling of Ovarian Cancer and Induced Epithelial-Mesenchymal Transition
Chen, C. (2023) · theses.fr (ABES) · doi:10.70675/9561117fzc645z4907za71czf4ba5d3659aa
Zhang, L., Xiao, L., Yang, H., & Wang, H. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1779209
Biomaterial-based Platforms for Modeling the Pre-metastatic Niche
Halim, M. S. A., Nadernezhad, A., Kopecky, C., Hauser, S., Kilian, K. A., & Loessner, D. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-30151-3.00005-x
Hahne, J. (2026) · Directory of Open access Books (OAPEN Foundation)
Natanzi, A. S., Ahmadi, E., Shahraki, S., Koupaei, A. E., & Kashani, H. H. (2026) · Advanced Composites and Hybrid Materials · doi:10.1007/s42114-026-02049-2
Eftekhari, B. S., Grogan, S. P., & DʼLima, D. D. (2026) · Biomimetics · doi:10.3390/biomimetics11090668
Xiong, W.-C., Cao, S., Li, J., & Ouyang, D. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.117439
Gynecological cancers on a chip: status, advances, and future
He, Y., & Shastri, V. P. (2026) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2026.1976083
Metadata
- Authors
- Saha, B., Mathur, T., Tronolone, J. J., Chokshi, M., Lokhande, G. K., Selahi, A., Gaharwar, A. K., Afshar-Kharghan, V., Sood, A. K., Bao, G., & Jain, A.
- Affiliations
- Texas A&M University (US)
- Rice University (US)
- Department of Benign Hematology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
- The University of Texas MD Anderson Cancer Center (US)
- Texas A&M Health Science Center (US)
- Corresponding author
- Jain, Abhishek
- ORCID
- Venue
- Science Advances
- Published
- 2021-07-23
- Volume
- 7
- Issue
- 30
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC8294767
- OpenAlex
- W3185380516
- Cited by
- 90
- References
- 56
- Citations by year
- 2026: 11 · 2025: 22 · 2024: 19 · 2023: 21 · 2022: 15 · 2021: 2
- FWCI
- 4.33
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Science Advances (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Rice Research Repository (Rice University) (submittedVersion, cc-by)
- Funders
- National Science Foundation (1944322)
- National Institutes of Health (R21EB025945, P30 CA016672, P50 CA217685, CA177909, R35 CA209904)
- National Institute of Biomedical Imaging and Bioengineering (R21EB025945)
- UVA Cancer Center (RR140081)
- National Science Foundation Graduate Research Fellowship (1650114)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- tumor microenvironment, ovarian cancer, organ-on-a-chip, glycoprotein VI, galectin-3, shear stress, antiplatelet therapy, metastasis, chemoresistance
- MeSH terms
- Blood Platelets, Humans, Ovarian Neoplasms, Platelet Aggregation Inhibitors, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.